Rebooting of Canadian medical isotope reactor delayed

Aug 13, 2009

A Canadian reactor that produced one-third of the world's supply of medical isotopes before it closed in May for repairs will remain offline at least until early 2010, nuclear authorities said Thursday.

Atomic Energy of Canada Limited (AECL) had previously estimated the stoppage would last only a few months, but a new analysis confirmed "nine sites likely requiring repair" at the Chalk River facility, 185 kilometers (115 miles) northwest of Ottawa.

High resolution scans also identified both "wall thinning and localized pitting that suggests different corrosion effects," which require further investigation, AECL said in a statement.

"Further guidance on a return to service date will be provided when more data is available," it said.

The half-century old National Research Universal reactor in Chalk River, Ontario was shut down on May 15 after a leak of radioactive water inside the reactor.

produced by the reactor are used to diagnose cancer and heart patients around the world. The shutdown has led to a global shortage of the precious radioactive material.

(c) 2009 AFP

Explore further: New drug sales help boost Novartis Q1 profit (Update)

add to favorites email to friend print save as pdf

Related Stories

A top supplier of medical isotopes closed through 2009

Jul 08, 2009

An aging Canadian nuclear reactor responsible for production of one-third of the isotopes used in medical radiation treatment around the world will be out of service through at least the end of 2009, authorities said Wednesday.

Officials seek cause of reactor shutdown

Nov 03, 2006

Authorities are investigating the cause of the nuclear reactor shutdown at Three Mile Island near Harrisburg, Pa., although no radiation leaked in the incident.

Scientists discover historic sample of bomb-grade plutonium

Feb 26, 2009

(PhysOrg.com) -- Scientists in Washington state are reporting the surprise discovery of the oldest known sample of reactor-produced bomb-grade plutonium, a historic relic from the infancy of America’s nuclear weapons program. ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Genetic code of the deadly tsetse fly unraveled

Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.